Summary
Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company provides its products under Vectra, Endopredict, myRisk, Prequel, Foresight, MyChoice CDx, BRACAnalysis CDx, myPath, GeneSight, Prolaris, and brand names. It operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has operations in the US and Europe. Myriad is headquartered in Salt Lake City, Utah, the US
Scope
- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments
- Intelligence on Myriad Genetics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Myriad Genetics, Inc.'s business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
Myriad Genetics, Inc.: Company Overview
Myriad Genetics, Inc.: Overview and Key Facts
Myriad Genetics, Inc.: Overview
Myriad Genetics, Inc.: Key Facts
Myriad Genetics, Inc.: Key Employees
Myriad Genetics, Inc.: Key Employee Biographies
Myriad Genetics, Inc.: Major Products and Services
Myriad Genetics, Inc.: Company History
Myriad Genetics, Inc.: Management Statement
Myriad Genetics, Inc.: Locations and Subsidiaries
Myriad Genetics, Inc.: Key Competitors
Myriad Genetics, Inc.: Company Analysis
Myriad Genetics, Inc.: Business Description
Myriad Genetics, Inc.: SWOT Analysis
Myriad Genetics, Inc.: SWOT Overview
Myriad Genetics, Inc.: Strengths
Myriad Genetics, Inc.: Weaknesses
Myriad Genetics, Inc.: Opportunities
Myriad Genetics, Inc.: Threats
Myriad Genetics, Inc.: Corporate Financial Deals Activity
Myriad Genetics, Inc.: Financial Deals Overview
Myriad Genetics, Inc.: Targets and Partners
Myriad Genetics, Inc.: Top Deals 2018 - 2022YTD*
Myriad Genetics, Inc.: Advisors
Myriad Genetics, Inc.: Top Legal Advisors
Myriad Genetics, Inc.: Top Financial Advisors
Myriad Genetics, Inc.: Mergers and Acquisitions
Myriad Genetics, Inc.: Capital Raising
Myriad Genetics, Inc.: Partnership
Myriad Genetics, Inc.: Divestments
Myriad Genetics, Inc.: Recent Developments
Myriad Genetics, Inc.: News and Events Summary
Myriad Genetics, Inc.: Corporate Governance
Myriad Genetics, Inc.: Financial Deals
Myriad Genetics, Inc.: Financial Performance
Myriad Genetics, Inc.: Market Developments
Myriad Genetics, Inc.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Myriad Genetics, Inc.: Key Facts
Table 2: Myriad Genetics, Inc.: Key Employees
Table 3: Myriad Genetics, Inc.: Company History
Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries
Table 5: Myriad Genetics, Inc.: Key Competitors
Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Myriad Genetics, Inc.: Targets and Partners
Table 10: Myriad Genetics, Inc.: Top Deals 2018 - 2022YTD*
Table 11: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Myriad Genetics, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 14: Myriad Genetics, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Table 15: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 16: Myriad Genetics, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 17: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 18: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 19: Myriad Genetics, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 20: Myriad Genetics, Inc.: Divestments by Geography (2018 - YTD*2022)
Table 21: Myriad Genetics, Inc.: News and Events Summary
Table 22: Myriad Genetics, Inc.: Corporate Governance
Table 23: Myriad Genetics, Inc.: Financial Deals
Table 24: Myriad Genetics, Inc.: Financial Performance
Table 25: Myriad Genetics, Inc.: Market Developments
Table 26: Myriad Genetics, Inc.: Regulatory and Legal Events
List of Figures
Figure 1: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Myriad Genetics, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 5: Myriad Genetics, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Figure 6: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 7: Myriad Genetics, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 8: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 9: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 10: Myriad Genetics, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 11: Myriad Genetics, Inc.: Divestments by Geography (2018 - YTD*2022)
